北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China
作者: He, Zhong1; Chen, Rong1; Zhou, Yingfang2; Geng, Li3; Zhang, Zhenyu4; Chen, Shuling2; Yao, Yanjun3; Lu, Junli4; Lin, Shouqing1
关键词: Vitex agnus castus ; Premenstrual syndrome ; Efficacy and safety
刊名: MATURITAS
发表日期: 2009-05-20
DOI: 10.1016/j.maturitas.2009.01.006
卷: 63, 期:1, 页:99-103
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Geriatrics & Gerontology ; Obstetrics & Gynecology
研究领域[WOS]: Geriatrics & Gerontology ; Obstetrics & Gynecology
关键词[WOS]: DYSPHORIC DISORDER ; TENSION SYNDROME ; CONTROLLED-TRIAL ; EXTRACT ; SYMPTOMS ; PREVALENCE ; MASTALGIA
英文摘要:

Objectives: To investigate the efficacy and safety of VAC BNO 1095 extract in Chinese women suffering from moderate to severe premenstrual syndrome (PMS).

Methods: Prospective, double-blind, placebo controlled, parallel-group, multi-center clinical trial design was employed. After screening and preparation phase lasting three cycles, Eligible patients were randomly assigned into treatment or placebo groups and had treatment with VAC extract or placebo for up to three cycles. Efficacy was assessed using the Chinese version PMS-diary (PMSD) and PMTS.

Results: Two hundred and seventeen women were eligible to enter the treatment phase (TP) and were randomly assigned into the treatment group (108) or the placebo group (109), 208 provided the efficacy data (treatment 104, placebo 104), and 202 completed the treatment phase (treatment 101, placebo 101). The mean total PMSD score decreased from 29.23 at baseline (0 cycle) to 6.41 at the termination (3rd cycle) for the treatment group and from 28.14 at baseline (0 cycle) to 12.64 at the termination (3rd cycle) for the placebo group. The total PMSD score of 3rd cycle was significantly lower than the baseline in both groups (p < 0.0001). The difference in the mean scores from the baseline to the 3rd cycle in the treatment group (22.71 +/- 10.33) was significantly lower than the difference in the placebo group (15.50 +/- 12.94, p < 0.0001). Results of PMTS were similar, the total scores for PMTS were significantly lower between the two groups (p < 0.01) and within each group (p < 0.01). The score was decreased from 26.17 +/- 4.79 to 9.92 +/- 9.01 for the treatment group, and from 27.10 +/- 4.76 to 14.59 +/- 10.69 for the placebo group. A placebo effect of 50% was found in the present study. No serious adverse event (SAE) occurred in both groups.

Conclusion: Vitex agnus castus (VAC BNO 1095 corresponding to 40 mg herbal drug) is a safe, well tolerated and effective drug of the treatment for Chinese women with the moderate to severe PMS. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

语种: 英语
WOS记录号: WOS:000267462300019
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/51842
Appears in Collections:北京大学第一临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China
2.Peking Univ, Hosp 1, Dept Obstet & Gynaecol, Beijing 100871, Peoples R China
3.Peking Univ, Hosp 3, Dept Obstet & Gynaecol, Beijing 100871, Peoples R China
4.Capital Med Univ, Beijing Chaoyang Hosp, Dept Obstet & Gynaecol, Beijing, Peoples R China

Recommended Citation:
He, Zhong,Chen, Rong,Zhou, Yingfang,et al. Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China[J]. MATURITAS,2009,63(1):99-103.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[He, Zhong]'s Articles
[Chen, Rong]'s Articles
[Zhou, Yingfang]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[He, Zhong]‘s Articles
[Chen, Rong]‘s Articles
[Zhou, Yingfang]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace